Contributions of Leukocytes to Vascular Injury and Thrombosis

  • R. G. Schaub
  • C. J. Dunn
  • C. Orlandi
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 86)


Naturally occuring coronary reperfusion or reperfusion following treatment with fibrinolytic agents and/or percutaneous transluminal angioplasty can limit the extent of myocardial damage in patients with acute myocardial infarction (1–3). However, there are some undesirable sequelae of reperfusion which may limit its beneficial effects. One of these undesirable events is the acceleration of the acute inflammatory reaction observed in the early course of myocardial infarction (4–6). The contribution of the leukocytes which accumulate during this inflammatory response to myocardial damage and expansion of the infarct zone has been described (7,8). However, less attention has been directed to the early adherence of leukocytes to the vascular endothelium of the coronary vessels within the ischemic area. Accumulation of activated leukocytes on vascular endothelium could lead to several undesirable consequences relative to reflow to the ischemic area. These include physical obstruction of small vessels by leukocyte aggregates and thrombosis of both large and small vessels by direct endothelial cell injury or the generation of procoagulant substances (9–11). This paper will review the mechanisms by which PMN’s can initiate thrombosis of blood vessels at or near sites of tissue injury.


Platelet Activate Factor Leukocyte Adhesion Superficial Femoral Artery Ischemic Area PROCOAGULANT Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gruentzig, A. R., Senning A., Siegenthaler, W.E., N. Eng. J. Med. 301:61–68,1979.CrossRefGoogle Scholar
  2. 2.
    Laffel, G.L and Braunwald, E. N. Eng. J. Med. 311:710–717,1984.CrossRefGoogle Scholar
  3. 3.
    Laffel, G.L and Braunwald, E. N. Eng. J. Med. 311:770–776,1984.CrossRefGoogle Scholar
  4. 4.
    Weiss, E.S., Ahmed S.A., Thakur, M.L, Welch, M.J., Colemann, R.E. and Sobel, B.E. Am. J. Cardiol. 40:195–199,1977.PubMedCrossRefGoogle Scholar
  5. 5.
    Thakur, M.L, Gottschalk, A. and Zart, B.L. Circulation 60:297–305, 1979.PubMedCrossRefGoogle Scholar
  6. 6.
    Mullane, K.M., Kraemer, R. and Smith, B. J. Pharmacol Methods 14:157–167,1985.PubMedCrossRefGoogle Scholar
  7. 7.
    Mullane, K.M., Salmon, J.A. and Kraemer, R. Fed. Proc. 46:2422–2433,1987.PubMedGoogle Scholar
  8. 8.
    Simpson, P.J., Michelson, J.K. and Lucchesi, B.R. Fed. Proc. 46:2413–2421,1987.PubMedGoogle Scholar
  9. 9.
    Schaub, R.G., Simmons, CA., Koets, M.H., Romano, P.J. and Stewart, G.J. Lab. Inves. 51:218–224,1984.Google Scholar
  10. 10.
    Engler, R.L, Schmid-Schoenbein, G.W. and Pavelec, R.S. Am. J. Path. 111:98–111, 1983.PubMedCentralPubMedGoogle Scholar
  11. 11.
    Lerner, R.G., Goldstein, R. and Nelson, J.C. Thromb. Res. 11:11–22, 1977.PubMedCrossRefGoogle Scholar
  12. 12.
    Stewart, G.J., Ritchie, W.G.M. and Lynch, P.R. Am. J. Path. 74:507–522,1974.PubMedCentralPubMedGoogle Scholar
  13. 13.
    Simmons, C.A., Burdick, M.D. and Schaub, R.G. J. Surg. Res. (In Press, 1987).Google Scholar
  14. 14.
    Orlandi, C.A. and Schaub, R.G. Circulation (In Press, 1987) (Abst).Google Scholar
  15. 15.
    Nishizawa, E.E. and Delia Coletta, A. Thrombos Haemostas 54:280, 1985 (Abst).Google Scholar
  16. 16.
    Stewart, G.J. In: Blood Vessels, Problems Arising at the Borders of Natural and Artificial Blood Vessels (Eds. S. Effert and J.D. Meyer-Erkelenz). Springer-Verlag, Berlin, Heidelberg, New York, 1977. pp. 71–76.Google Scholar
  17. 17.
    Schaub, R.G., Lynch, P.R. and Stewart, G.J. Surgery 83:411–424,1978.PubMedGoogle Scholar
  18. 18.
    Ward, P.A. J. Exp. Med. 126:189–206,1967.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Ford-Hutchinson, A.W., Bray, M.A., Doig, M.V., Shipley, M.E. and Smith, M.J. Nature 286:264–265,1980.PubMedCrossRefGoogle Scholar
  20. 20.
    Henson, P.M. Agents Actions 11: 545–547,1981.PubMedCrossRefGoogle Scholar
  21. 21.
    Shaw, J.O., Pinckard, R.N., Ferrigni, K.S., McManus, L.M. and Hanahan, D.J. J. Immunol. 127:1250–1255,1981.PubMedGoogle Scholar
  22. 22.
    O’Brien, R.F., Steton, M.P., Makarski, J.S., Center, D.M. and Rounds, S. Am. Rev. Respir. Dis. 130:103–109,1984.PubMedGoogle Scholar
  23. 23.
    Palmer, R.M.J., Stepney, R.J., Higgs, C.A. and Eakins, K.E. Prostaglandins 20:411–418,1980.PubMedCrossRefGoogle Scholar
  24. 24.
    Piper, P.J. and Galton, S.A. Prostaglandins 28:905–914,1984.PubMedCrossRefGoogle Scholar
  25. 25.
    Lefer, A.M., Roth, D.M., Lefer, D.J. and Smith, J.B. Nauyn-Schmiedberg’s Arch. Pharmacol. 326:186–189,1984.CrossRefGoogle Scholar
  26. 26.
    Denzlinger, C, Rapp, S., Hagmann, W. and Keppler, D. Science 230:330–332,1985.PubMedCrossRefGoogle Scholar
  27. 27.
    Denzlinger, C, Gahlmann, A., Scheuber, P.H., Wilker, D., Hammer, D.K. and Keppler, D. J. Biol. Chem. 261:15601–15606,1986.PubMedGoogle Scholar
  28. 28.
    Mclntyre, T.M., Zimmerman, G.A. and Prescott, S.M. Proc. Natl. Acad. Sci. USA 87:2204–2208, 1986.CrossRefGoogle Scholar
  29. 29.
    Lindbom, L., Hedqvest, P., Dahlen, S-E, Lindren, L.A. and Arfors, K.E. Acta Physiol. Scand. 116:105–108,1982.PubMedCrossRefGoogle Scholar
  30. 30.
    Gimbrone, M.A., Jr., Brock, A.F. and Schafer, A.I. J. Clin. Invest. 74:1552–1555,1984.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Malmston, C.L., Palmblad, J., Uden, A-M, Radmark, O., Engsedt, L. and Samuelsson,B. Acta Physiol. Scand. 110:449–451,1980.CrossRefGoogle Scholar
  32. 32.
    Schaub, R.G., Yamashita, A. Exp. Mol. Path. 45:343–353,1986.CrossRefGoogle Scholar
  33. 33.
    Schaub, R.G., Yamashita, A., Simmons, C.A., Romano, P.J. and Burdick, M.D. In: Leukocyte Emigration and its Sequelae (Ed. H.Z. Movat) Karger, Basel, 1987, pp. 62–68.Google Scholar
  34. 34.
    Sacks, T., Moldow, CF., Craddock, P.R., Bowers, T.K., Jacob, H.S. J. Clin. Invest. 61:1161–1167, 1978.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Weiss, S.J., Young, J., LoBuglio, A.F., Slivka, A., Nimeh, N.F. J. Clin. Invest. 68:714–721,1981.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    McManus, L.M., Hanahan, D.J., Pinckard, R.N. J. Clin. Invest. 67:903–906,1980.CrossRefGoogle Scholar
  37. 37.
    Niemetz, J., Marcus, A.J. J. Clin. Invest. 54:1437–1443, 1974.PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Nishizawa, E.E., Delia Coletta, A.A. Thromb. Res. 35:485–499,1984.PubMedCrossRefGoogle Scholar
  39. 39.
    Yoshinaga, M., Goto, F., Goto, K., Ohkawara, S., Kitamura, M., Mori, S. In: Leukocyte Emigration and Its Sequelae (Ed. H.Z. Movat) Karger, Basel, 1987, pp. 169–180.Google Scholar
  40. 40.
    Schaub, R.G., Dunn, C.J., Tracey, D.E., Fleming, W.E., Burdick, M.D. Thrombos Haemostas. (In Press, 1987) (Abst).Google Scholar
  41. 41.
    Dunn, C.J., Fleming, W.E. Eur. J. Rheum, and Inflamm. 7:80–86,1984.Google Scholar
  42. 42.
    Bevilacqua M.P., Pober, J.S., Majeau, G.R., Cotran, R.S., Gimbrone, M. A. J. Exp. Med. 160:618–623,1984.PubMedCrossRefGoogle Scholar
  43. 43.
    Emeis, J.J., Kooistra,T. J. Exp. Med. 163:1260–1266,1986.CrossRefGoogle Scholar
  44. 44.
    Nawroth, P.P., Handley, D.A., Esmon, CT., Stern, D.M. Proc. Natl. Acad. Sci. USA 83:3460–3464,1986.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Dunn, C.J., Schaub, R.G., Fleming, W.E., Gibbons, AJ. In: Leukocyte Emigration and Its Sequelae (Ed. H.Z. Movat) Karger, Basel, 1987, pp. 169–180.Google Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • R. G. Schaub
    • 1
  • C. J. Dunn
    • 1
  • C. Orlandi
    • 1
  1. 1.Atherosclerosis and Thrombosis Research and Hypersensitivity Diseases ResearchThe Upjohn CompanyKalamazooUSA

Personalised recommendations